UBS UBS Group AG

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

Date: November 3, 2015

UBS Group AG

Commission File Number: 1-36764

UBS AG

Commission File Number: 1-15060

(Registrants' Names)

Bahnhofstrasse 45, Zurich, Switzerland, and

Aeschenvorstadt 1, Basel, Switzerland

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40-F.

This Form 6-K consists of the UBS Group AG (consolidated) BIS Basel III leverage ratio information as of 30 September 2015, published today by the registrants, which appears immediately following this page.

UBS Group AG (consolidated) BIS Basel III leverage ratio information

This document provides BIS Basel III leverage ratio information as of 30 September 2015, as required by the revised FINMA Circular 2008 / 22 “Disclosure – banks.”

BIS Basel III leverage ratio disclosure requirements

On 1 January 2015, disclosure requirements for the leverage ratio in accordance with BIS Basel III regulations came into effect in Switzerland, and we are required to disclose BIS Basel III leverage ratio information on a quarterly basis.

The tables in the following section provide BIS Basel III leverage ratio information as of 30 September 2015 according to the current disclosure requirements.

The BIS Basel III leverage ratio is calculated by dividing the period-end tier 1 capital by the period-end BIS Basel III leverage ratio denominator (LRD), which consists of IFRS on-balance sheet assets and off-balance sheet items adjusted for netting of derivatives, eligible cash variation margin netting, net notional amounts or adjustment of add-ons for written credit derivatives as well as an additional charge for counterparty credit risk related to securities financing transactions.

The table “Reconciliation of IFRS total assets to BIS Basel III total on-balance sheet exposures excluding derivatives and securities financing transactions” below shows the difference between total IFRS assets per IFRS consolidation scope and on-balance sheet exposures, which is shown in the “BIS Basel III leverage ratio common disclosure” table on the next page. The difference is due to the application of the regulatory scope of consolidation for the purpose of the BIS Basel III calculation. In addition, carrying values for derivative financial instruments and securities financing transactions are deducted from IFRS total assets. They are measured differently under BIS Basel III leverage ratio rules and therefore added back in separate exposure line items in the “BIS Basel III leverage ratio common disclosure” table on the next page.

®   Refer to our third quarter 2015 report for information on our Swiss SRB leverage ratio as of 30 September 2015

®   Refer to the “UBS Group AG consolidated supplemental disclosures required under Basel III Pillar 3 regulations” section of our Annual Report 2014, and our UBS Group Basel III Pillar 3 First Half 2015 Report in the “Pillar 3, SEC filings & other disclosures” section at www.ubs.com/investors  for more information on the regulatory scope of consolidation

BIS Basel III leverage ratio

As of 30 September 2015, our BIS Basel III leverage ratio was 3.9% on a fully applied basis and 4.7% on a phase-in basis. The BIS Basel III LRD was CHF 936 billion on a fully applied basis and CHF 941 billion on a phase-in basis.

®   Refer to our third quarter 2015 report for information on our BIS Basel III leverage ratio movements

The naming convention in the following table is based on BIS guidance and does not reflect UBS’s naming convention used in our external reports.

The naming convention in the following table is based on BIS guidance and does not reflect UBS’s naming convention used in our external reports.

This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-204908) and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; and 333-200665), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Form 6-K’s of UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UBS Group AG

By: _/s/ David Kelly_____________

Name:  David Kelly

Title:    Managing Director

By: _/s/ Sarah M. Starkweather_____

Name:  Sarah M. Starkweather

Title:    Executive Director

UBS AG

By: _/s/ David Kelly_____________

Name:  David Kelly

Title:    Managing Director

By: _/s/ Sarah M. Starkweather_____

Name:  Sarah M. Starkweather

Title:    Executive Director

Date:  November 3, 2015